The FDA cleared a six-day Deep TMS treatment schedule for major depressive disorder, but availability and insurance coverage will vary.
What the FDA cleared
The U.S. Food and Drug Administration cleared an accelerated protocol for a specific Deep TMS system used to treat major depressive disorder. The cleared schedule condenses treatment into six days rather than the more common course of weekday sessions spread across several weeks.
Why this may matter in Nevada
A shorter schedule could reduce repeated travel for some patients, especially people who live far from a treatment center. That possibility is particularly relevant in a large state where specialty care is concentrated around population centers.
Important limits
FDA clearance applies to the specific device and protocol reviewed by the agency. It does not mean that every TMS machine can use the same schedule. It also does not establish insurance coverage, guarantee that a Nevada clinic offers the protocol, or show that the schedule is right for every patient.
The manufacturer reported trial results supporting the application, but patients should distinguish company-reported findings from independent long-term evidence.
Questions to ask a clinic
- Is this exact device and FDA-cleared protocol available?
- How many sessions take place each day, and how are breaks handled?
- Is the accelerated schedule covered by my health plan?
- What evidence and side-effect information apply to my diagnosis?
- What follow-up or maintenance care may be recommended?
A clinician should review diagnosis, treatment history, contraindications and practical needs before recommending any TMS schedule.
More Nevada reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.